ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $80,902,000 | -22.0% | 2,563,441 | 0.0% | 2.62% | +4.8% |
Q4 2021 | $103,742,000 | -27.4% | 2,563,441 | -37.5% | 2.50% | -26.1% |
Q3 2021 | $142,984,000 | +12.9% | 4,100,475 | -11.1% | 3.39% | +31.4% |
Q2 2021 | $126,695,000 | -4.5% | 4,613,818 | -2.3% | 2.58% | -51.7% |
Q1 2021 | $132,632,000 | +1.2% | 4,723,348 | -6.5% | 5.35% | -15.0% |
Q4 2020 | $131,092,000 | +51.5% | 5,049,786 | 0.0% | 6.29% | +54.7% |
Q3 2020 | $86,553,000 | -30.7% | 5,049,786 | 0.0% | 4.07% | -29.5% |
Q2 2020 | $124,932,000 | +78.2% | 5,049,786 | 0.0% | 5.77% | +25.4% |
Q1 2020 | $70,091,000 | +37.4% | 5,049,786 | 0.0% | 4.60% | +49.1% |
Q4 2019 | $51,003,000 | +11.0% | 5,049,786 | 0.0% | 3.08% | +123.3% |
Q3 2019 | $45,953,000 | +14.5% | 5,049,786 | 0.0% | 1.38% | +81.2% |
Q2 2019 | $40,146,000 | -36.3% | 5,049,786 | 0.0% | 0.76% | -76.6% |
Q1 2019 | $63,072,000 | +16.0% | 5,049,786 | 0.0% | 3.26% | -49.3% |
Q4 2018 | $54,386,000 | -22.7% | 5,049,786 | 0.0% | 6.43% | -4.6% |
Q3 2018 | $70,394,000 | +13.9% | 5,049,786 | 0.0% | 6.74% | +29.9% |
Q2 2018 | $61,809,000 | -20.7% | 5,049,786 | 0.0% | 5.19% | -59.1% |
Q1 2018 | $77,969,000 | – | 5,049,786 | – | 12.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |